What is the price target for ESNT stock?
13 analysts have analysed ESNT and the average price target is 65.97 USD. This implies a price increase of 2.2% is expected in the next year compared to the current price of 64.55.
NYSE:ESNT • BMG3198U1027
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ESSENT GROUP LTD (ESNT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-04-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-12 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-17 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-01-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-02 | Roth Capital | Maintains | Buy -> Buy |
| 2025-12-18 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-10-07 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-10-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-07 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
| 2025-05-23 | Compass Point | Maintains | Buy -> Buy |
| 2025-04-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-04-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-02-18 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-02-18 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-01-06 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-12-10 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-12-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-11-05 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.11B 10.89% | 1.243B 12.00% | 1.261B 1.45% | 1.275B 1.12% | 1.318B 3.37% | 1.428B 8.35% | |
| EBITDA YoY % growth | 862.161M -14.37% | 896.593M 3.99% | 859.791M -4.10% | N/A | N/A | N/A | |
| EBIT YoY % growth | 857.636M -14.56% | 890.81M 3.87% | 854.558M -4.07% | 1.067B 24.86% | 1.124B 5.34% | 813.96M -27.58% | |
| Operating Margin | 77.28% | 71.67% | 67.77% | 83.69% | 85.28% | 57.00% | |
| EPS YoY % growth | 6.50 -15.69% | 6.84 5.23% | 6.89 0.73% | 7.27 5.52% | 7.78 6.98% | 8.27 6.36% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.72 1.92% | 1.85 -4.03% | 1.85 10.86% | 1.83 14.48% | 1.90 10.34% | 2.00 8.10% | 1.98 7.18% | 1.99 8.80% | 2.16 13.78% | 2.36 17.68% | 2.33 17.21% | 2.30 15.16% |
| Revenue Q2Q % growth | 313.4M -1.31% | 315.12M -1.26% | 317.83M 1.92% | 317.28M 1.56% | 301.29M -3.86% | 305.04M -3.20% | 304.25M -4.27% | 303.02M -4.49% | 332.46M 10.35% | 335.64M 10.03% | 337.63M 10.97% | 336.81M 11.15% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 247.45M 15.01% | 266.55M 11.38% | 277.36M 33.73% | 275.42M 42.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed ESNT and the average price target is 65.97 USD. This implies a price increase of 2.2% is expected in the next year compared to the current price of 64.55.
ESSENT GROUP LTD (ESNT) will report earnings on 2026-05-01, before the market open.
The consensus EPS estimate for the next earnings of ESSENT GROUP LTD (ESNT) is 1.72 USD and the consensus revenue estimate is 313.40M USD.
The consensus rating for ESSENT GROUP LTD (ESNT) is 75.3846 / 100 . This indicates that analysts generally have a positive outlook on the stock.